Skip to main content
. 2017 Dec 7;9(2):241–252. doi: 10.1111/1759-7714.12570

Table 1.

mPP schedules according to cisplatin/carboplatin‐based doublets

24 mPP doublets
Cisplatin‐based mPP doublets 2 Cisplatin 75 mg/m2 day 1 ‐ Pemetrexed 400 mg/m2 day 1 q 21
2 Cisplatin 70 mg/m2 day 1 ‐ Pemetrexed 500 mg/m2 day 1 q 21
1 Cisplatin 70 mg/m2 day 1 ‐ Pemetrexed 400 mg/m2 day 1 q 21
2 Cisplatin 60 mg/m2 day 1 ‐ Pemetrexed 500 mg/m2 day 1 q 21
1 Cisplatin 60 mg/m2 day 1 ‐ Pemetrexed 375 mg/m2 day 1 q 21
Carboplatin‐based mPP doublets 5 Carboplatin (AUC 5) day 1 ‐ Pemetrexed 400 mg/m2 day 1 q 21
1 Carboplatin (AUC 2.5) days 1, 8 ‐ Pemetrexed 500 mg/m2 day 1 q 21
1 Carboplatin (AUC 4) day 1 ‐ Pemetrexed 400 mg/m2 day 1 q 21
2 Carboplatin (AUC 2.5) days 1, 8 ‐ Pemetrexed 400 mg/m2 day 1 q 21
3 Carboplatin (AUC 2) days 1, 8 ‐ Pemetrexed 400 mg/m2 day 1 q 21
3 Carboplatin (AUC 2) days 1, 8 ‐ Pemetrexed 375 mg/m2 day 1 q 21
1 Carboplatin 200 mg days 1, 8 ‐ Pemetrexed 300 mg/m2 day 1 q 21

AUC, area under the curve; mPP, modified platinum‐pemetrexed.